Johnson & Johnson
JNJ
#23
Rank
NZ$1.090 T
Marketcap
NZ$452.43
Share price
-2.00%
Change (1 day)
38.52%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$15.18

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$15.60. In 2025 the company made an earnings per share (EPS) of NZ$19.90 an increase over its 2024 EPS that were of NZ$11.95.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$15.18-23.7%
2025NZ$19.9066.46%
2024NZ$11.95-53.6%
2023NZ$25.76111.16%
2022NZ$12.20-13.84%
2021NZ$14.1641.81%
2020NZ$9.98-18.92%
2019NZ$12.3221.2%
2018NZ$10.161125.3%
2017NZ$0.83-92.23%
2016NZ$10.677.37%
2015NZ$9.94-4.16%
2014NZ$10.3718.1%
2013NZ$8.7824.88%
2012NZ$7.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.90-23.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.57-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.29-53.28%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$53.38 242.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.40-78.21%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ-$4.64-129.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$17.38 11.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.26-85.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.71-63.39%๐Ÿ‡ฌ๐Ÿ‡ง UK